Following the combination, the M1/M2 ratio increased, CD206 expression (an M2 marker) was down-regulated, and iNOS (inducible nitric oxide synthase, an M1 marker) expression was up-regulated, thereby exerting anti-tumor immune effects through regulation of macrophage polarization. The gene discussed is NOS2; the disease is neoplasm.